Chemical derivatives binding very specifically with G-quadruplex DNA structures and use thereof as a specific anticancer agent

Details for Australian Patent Application No. 2004210753 (hide)

Owner Institut Curie Centre National de la Recherche Scientifique Aventis Pharma S.A. Universite Reims Champagne-Ardenne Museum National D'Histoire Naturelle Commissariat A L'Energie Atomique

International Classifications

Event Publications

18 August 2005 PCT application entered the National Phase

PCT publication WO2004/072027 Priority application(s): WO2004/072027

2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.